Compounds > ribavirin
Page last updated: 2024-08-16

ribavirin and Leishmaniasis, Visceral

ribavirin has been researched along with Leishmaniasis, Visceral in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cascio, A; Cervo, A; Colomba, C; Di Carlo, P; Firenze, A; Saporito, L; Tolomeo, M; Trizzino, M1
Dinçer, E; Korukluoğlu, G; Özkul, A; Sucaklı, IA; Tavil, B; Tezer, H; Tunç, B; Uyar, Y1

Other Studies

2 other study(ies) available for ribavirin and Leishmaniasis, Visceral

ArticleYear
Direct-acting antivirals and visceral leishmaniasis: a case report.
    BMC infectious diseases, 2019, Apr-18, Volume: 19, Issue:1

    Topics: Aged; Amphotericin B; Antiprotozoal Agents; Antiviral Agents; Coinfection; Hepatitis C, Chronic; Humans; Leishmania infantum; Leishmaniasis, Visceral; Male; Ribavirin; Sofosbuvir

2019
Concurrent Crimean-Congo hemorrhagic fever and visceral leishmaniasis in a Turkish girl.
    Vector borne and zoonotic diseases (Larchmont, N.Y.), 2011, Volume: 11, Issue:6

    Topics: Adult; Amphotericin B; Antiprotozoal Agents; Antiviral Agents; Fatal Outcome; Female; Hemorrhagic Fever, Crimean; Humans; Infant; Leishmaniasis, Visceral; Male; Ribavirin

2011